We are investigating the effects of human umbilical cord blood mononuclear progenitor cells (HUCBC) for the treatment of acute myocardial infarction because human cord blood is a readily available and an abundant source of primitive cells that may be beneficial in myocardial repair. However, there is currently no scientific consensus on precisely when to inject stem/progenitor cells for the optimal treatment of acute myocardial infarction. We used an in vitro assay to determine the attraction of infarcted rat myocardium at 1, 2, 2.5, 3, 6, 12, 24, 48, and 96 h after left anterior descending coronary artery (LAD) occlusion from 45 rats for HUCBC in order to determine the optimal time to transplant HUCBC after myocardial infarction. Our assay is based on the migration of fluorescent DAPI-labeled HUCBC from wells in an upper chamber of a modified Boyden apparatus through a semiporous polycarbonate membrane into wells in a lower chamber that contain either normal or infarcted myocardium. DAPI-labeled HUCBC (100,000) were placed in each of the separate wells above the membrane that corresponded to normal or infarct homogenate in the lower wells. The greatest HUCBC migration to infarcted myocardium occurred at 2 h and 24 h after LAD occlusion in comparison with normal controls. A total of 76,331 ± 3384 HUCBC migrated to infarcted myocardium at 2 h and 69,911 ± 2732 at 24 h after LAD occlusion (both p < 0.001) and significantly exceeded HUCBC migration to normal heart homogenate. The HUCBC migration remained greatest at 2 and 24 h after LAD occlusion when the number of migrated cells was adjusted for the size of each myocardial infarction. Injection of 10 6 HUCBC in saline into infarcted myocardium of non immunosuppressed rats within 2 h (n = 10) or at 24 h (n = 5) after LAD occlusion resulted in infarction sizes 1 month later of 6.4 ± 0.01% and 8.4 ± 0.02% of the total left ventricular muscle area, respectively, in comparison with infarction sizes of 24.5 ± 0.02% (n = 10) in infarcted rat hearts treated with only saline (p < 0.005). Acute myocardial infarction in rats treated with only saline increased the myocardial concentration of tumor necrosis factor-α (TNF-α) from 6.9 ± 0.8% to 51.3 ± 4.6%, monocyte/macrophage chemoattractant protein (MCP-1) from 10.5 ± 1.1% to 39.2 ± 2.0%, monocyte inflammatory protein (MIP) from 10.6 ± 1.6% to 23.1 ± 1.5%, and interferon-γ (INF-γ) from 8.9 ± 0.3% to 25.0 ± 1.7% between 2 and 12 h after coronary occlusion in comparison with known controls (all p < 0.001). In contrast, the myocardial concentrations of these cytokines in rat hearts treated with HUCBC did not significantly change from the controls at 2, 6, 12, and 24 h after coronary occlusion. The present investigations suggest that infarcted myocardium significantly attracts HUCBC, that HUCBC can substantially reduce myocardial infarction size, and that HUCBC can limit the expression of TNF-α, MCP-1, MIP, and INF-γ in acutely infarcted myocardium.
INTRODUCTION
people die from acute complications of myocardial infarction (2) . A critical determinant of the prognosis of every patient with coronary artery disease is the size of Each year more than 1 million Americans experience an acute myocardial infarction and approximately 500,000 their myocardial infarction, which directly determines 648 HENNING ET AL.
the magnitude of heart dilation, the degree of impair-were adjusted to 1 million viable mononuclear cells/0.5 ml saline. The HUCBC contained 1.0-2.0% CD34 + cells ment of heart pump function, the development of heart failure, and ultimately the prognosis of the patient.
as determined by flow cytometry. In order to limit myocardial infarction size and mini-Fluorescent Labeling of HUCBC mize or prevent heart failure, cardiovascular researchers have recently begun to transplant stem cells into infarcted HUCBC previously stored at −196°C were thawed at 37°C and added to 7 ml Hank's buffered salt solution hearts. Human embryonic stem cells, skeletal muscle myoblasts, and bone marrow stem cells have been trans-(HBSS) (Invitrogen). The sample was then centrifuged at 1100 rpm at 8°C for 7 min. The resulting supernatant planted into hearts (26) . Although each cell type has some advantages, they also have distinct limitations. For was removed and the cell pellet was resuspended in 800 µl Isolyte-S, pH 7.4 (Braun Medical) containing 100 µl example, the use of human embryonic stem cells has been significantly restricted because of ethical, legal, DNase (Worthington Biochemical). Twenty microliters of the HUCBC was removed and the cell number and and societal issues. Moreover, skeletal myoblasts and bone marrow stem cells are not readily available for the viability determined using a cell counter (Beckman Coulter). Seventy-five microliters of 1 mg/ml 4′,6-diamid-immediate treatment of patients with acute myocardial infarction. In addition, there is no scientific consensus ino-2-phenylindole (DAPI) (Sigma-Aldrich) solution was then added to the cell solution and the cells were about the optimal time for stem cell transplantation after myocardial infarction.
allowed to incubate on ice for 1 h. Following the incubation period, the solution was centrifuged at 1200 rpm at We have recently begun to investigate the transplantation of primitive mononuclear progenitor cells isolated 8°C for 10 min. The resultant supernatant was decanted and the cells were resuspended in 10 ml of phosphate from human umbilical cord blood to limit myocardial infarction size and limit or prevent the development of buffer solution (PBS) (Invitrogen). This resuspension and centrifugation step was repeated three more times. heart failure (20) . Because 4 million births occur each year in the US, there is a tremendous resource of human After decanting the final 10 ml of PBS, the cell pellet was resuspended in 1 ml saline and placed on ice. umbilical cord blood mononuclear progenitor cells (HUCBC) potentially available for cardiac transplanta-Normal and Infarcted Heart Extractions tion. Human umbilical cord blood is an extremely rich source of hematopoietic and mesenchymal progenitor All rats received care in compliance with the principles of laboratory animal care and in accordance with cells that have immature immunogenicity that significantly reduces the risks of cell rejection by the transplant the University of South Florida's Institutional Animal Care and Use Committee (IACUC) and the Guide for recipient (5) . Our initial results in rats with acute myocardial infarction indicate that HUCBC, when directly Care and Use of Laboratory Animals of the National Institutes of Health. Forty-five male Sprague-Dawley injected into infarcted myocardium, significantly limit infarct size and improve left ventricular function but do rats (Harlan) weighing between 150 and 200 g were anesthetized with 3-5% isoflurane by inhalation, intubated, not stimulate an immunological rejection response (20) . We therefore sought in the present investigation to de-and placed on mechanical ventilation with continuous isoflurane and oxygen. A thoracotomy was performed termine the optimal time to inject HUCBC and to determine the effects of HUCBC on acute myocardial infarc-through the left fifth intercostal space. The pericardium was opened and the left anterior descending coronary tions when injected at these optimal times. artery (LAD) was ligated with 3-0 silk suture. Infarction
MATERIALS AND METHODS
of the anterior wall of the left ventricle was confirmed Acquisition of HUCBC by the presence of a pale myocardial color in the anterior myocardial wall after coronary occlusion. The left Cryopreserved (−196°C) mononuclear fractions of HUCBC were donated to us by a human cord cell blood ventricle of each heart was visually divided into a grid of nine equal sections and the number of sections occu-bank (Saneron CCEL Therapeutics, Inc). Maternal blood was examined for HIV, HTLV, hepatitis, syphilis, and pied by each infarction counted and recorded. The chest was then closed in three layers and each rat was allowed cytomegalovirus and the cord blood was rejected if any test was positive. Cryopreserved HUCBC were thawed to recover. Buprenorphine (0.05-0.5 mg/kg) was given for postoperative analgesia every 6-8 h. Groups of five at 37°C and transferred into a centrifuge tube containing Isolyte S, pH 7.4 (Braun McGaw). The cells were exten-rats at 1, 2, 2.5, 3, 6, 12, 24, 48, and 96 h after LAD occlusion were anesthetized with phenobarbital (60 mg/ sively washed, centrifuged at 1000 rpm for 7 min, the supernatant discarded, and the HUCBC viability deter-kg, IP). The heart of each rat was rapidly excised and rinsed in physiological saline. The hearts were then flash mined. The HUCBC viability was 85-90% using the trypan blue dye exclusion method. HUCBC volumes frozen and stored in liquid nitrogen at −196°C. Normal hearts from 10 rats that had not undergone any surgical in order to deposit any partially migrated HUCBC in the membranes into the lower wells. The membranes were ligation of the coronary vessels were obtained in the same manner and used as normal controls.
then removed and the lower wells were read in a fluorescent reader (Dynex MFX Microtiter) with a DAPI-Cell Migration specific filter set (absorption wavelength 358 nm, emission wavelength 461 nm) to determine the number of The hearts were thawed at 37°C and the great vessels and atria removed. The ventricular tissue was then HUCBC that migrated. The variability of the measurement technique was ≤ ±5%. Figure 2 shows a represen-weighed and placed in PBS at a concentration of 75 mg heart tissue per milliliter of PBS. The ventricular tissue tative standard curve. Over the range between 0 and 80,000 cells there is a linear relationship between the in PBS was then homogenized until no visible tissue particles were present in the solution. Three hundred mi-luminescent signals and the number of HUCBC (R 2 = 0.93). The numbers of migrated cells for each of the five croliters of normal or infarcted ventricular homogenate from each heart was placed into three separate wells of hearts at each time after LAD occlusion were determined and expressed as the mean ± SEM for each inter-the 96-well modified Boyden chambers (Neuroprobe). A 25 × 80 mm polycarbonate membrane with 5 µm pore val. Because the total number of migrated cells to each myocardial infarction may be determined, at least in size (Neuroprobe) was placed on top of the lower chamber wells. The membrane has a pore density of 4000/ part, by the size of the infarction, we divided each migration cell number by the total number of sections oc-mm 2 , with a pore area of 19.365 mm 2 , and a pore area/ unit area of 7.85%. The diameter of the HUCBC was cupied by each infarct in order to adjust for infarction size. 8 ± 2 µm. One hundred thousand DAPI-fluorescentlabeled HUCBC in saline solution were placed in each HUCBC Injection Protocol Into Rats of the wells above the heart homogenates. In addition, With Myocardial Infarctions negative controls were set up in one row of wells in which HUCBC were placed in upper wells but the corre-Thirty rats were anesthetized with 3-5% isoflurane and a left thoracotomy was performed. The pericardium sponding bottom wells contained only suspension media in order to determine and correct for random cell migra-was opened and the LAD permanently ligated. In 10 rats, 10 6 HUCBC in 0.5 ml of saline were directly in-tion. Serial dilutions of DAPI-labeled HUCBC from 0 to 80,000 were also placed in the first column of wells jected into the apex of the left ventricle within 2 h after the coronary artery ligation. The injections were made in each lower chamber for standard curve calibration purposes in order to compare cell fluorescence intensity into the apex of the left ventricle, which is the most muscular portion of the ventricle, in order to ensure di-to a known number of HUCBC. No HUCBC were placed in the first column of wells above these calibra-rect myocardial distribution of HUCBC and also allow migration of HUCBC to the area of infarction in the tion cells. Figure 1 shows a modified Boyden chamber chem-anterior myocardial wall. In 10 rats only 0.5 ml of saline was injected into the apex of the left ventricle within 2 oattraction apparatus (Neuorprobe). After an incubation period of 4 h at 37°C in a water-jacketed incubator with h after the coronary artery ligation. In 10 rats, the LAD was ligated and no injection was performed at that time. 5% CO 2 and air, the upper wells were rinsed with PBS to remove any nonmigrated cells. The modified Boyden
In order to quantitate the size of each infarction in each rat, the left ventricle of each heart was visually divided apparatus was then centrifuged at 1200 rpm for 7 min Figure 1 . The modified Boyden chamber chemoattraction apparatus is shown with the lower chamber and wells, the 25 × 80-mm framed polycarbonate membrane with 5 µm pore size, and the superimposed upper wells. into a grid of nine equal sections and the number of of the infarcted myocardium and the area of normal myocardium in the left ventricle. sections occupied by each infarction counted and recorded. Each thoracotomy was then closed in three lay-Cytokine and Chemokine Determinations ers and each rat was allowed to recover. Buprenorphine (0.05-0.5 mg/kg) was given for postoperative analge-
To determine the cytokines and chemokines present in infarcted rat myocardium, a cytokine/chemokine anti-sia every 6-8 h. In the 10 rats with myocardial infarctions that were not previously treated with injections, a body array kit (RayBiotech) that simultaneously profiles 18 cytokines/chemokines and permits comparison with second thoracotomy was performed 24 h after the LAD occlusion. One million HUCBC in 0.5 ml of saline, known positive controls was used. Infarcted hearts injected with either HUCBC in saline or saline alone were then injected into the apex of the left ventricle in five rats and only 0.5 ml of saline was injected in five within 2 h after coronary occlusion were extracted from rats at 2 (n = 4), 6 (n = 4), 12 (n = 4), and 24 h (n = 6) rats. Each thoracotomy was then closed in three separate layers and each rat was allowed to recover. Bu-after acute coronary occlusion. The hearts were flash frozen in liquid nitrogen and then stored at −86°C. The prenorphine (0.05-0.5 mg/kg) was given for postoperative analgesia every 6-8 h. Immunosuppressive drug hearts were thawed at 25°C and the left ventricle dissected. The ventricular tissue was then placed in 750 µl therapy was not given to any rat at any time. One month after the LAD occlusion, all rats were sacrificed of lysis buffer [20 mM Tris, pH 7.5, 0.3 M NaCl, 2% sodium deoxycholate, 2% TX-100, plus a protease in-and the hearts extracted. The ventricles of each heart were cut into 2-mm slices parallel to the atrioventricu-hibitor cocktail (Roche)] and homogenized until no visible tissue particles remained. The homogenate was then lar sulcus. Each ventricular slice was rinsed in saline and then immersed in 1% triphenyltetrazolium chloride placed on a rocker plate at 4°C for 2 h and then centrifuged at 12000 rpm for 30 min at 4°C. The protein con-(TTC) solution containing 0.2 M Tris. The myocardial slices were then rinsed in saline and photographed with centration of the supernatant was then determined by the Bradford Assay with bovine serum albumin as a stan-a digital camera (Nikon). The heart slices were then stored in 10% formalin. Triphenyltetrazolium forms a dard. Protein (50 µg) from each heart supernatant was then added to 2 ml of blocking buffer (RayBiotech). red precipitate in the presence of intact dehydrogenase enzymes in normal myocardium whereas infarcted and Each solution was placed in a plastic tray with a separate cytokine array membrane (RayBiotech) and incubated damaged myocardium lacks these enzymes and appears white to light pink in color within 30 min after acute for 3 h at room temperature on a rocker plate. After incubation, the solution was removed and each mem-coronary occlusion (1). Tetrazolium does not stain HUCBC but has a diagnostic efficiency of 88% for myo-brane incubated for 12 h at 4°C with a mixture of biotinylated cytokine primary antibodies to CINC2, CINC3, cardial infarction (1) . Computer Imaging Software (Im-agePro Plus) was utilized for determination of the area CNTF, Fractaline, GM-CSF, IL-1α, IL-1β, IL-4, IL-6, IL-10, LIX, IFN-γ, Leptin, MCP-1, MIP, β-NGF, TNF-the greatest HUCBC migration to infarcted myocardium persisted at 2 and 24 h after LAD occlusion (p < 0.01) α, and VEGF (RayBiotech) on a rocker plate. The membranes were rinsed and HRP conjugated secondary anti-( Fig. 4) . HUCBC migration to infarcted myocardium was also significant (p < 0.05) at 2.5 h after acute coro-bodies were added to each membrane. The membranes were incubated at room temperature for 2 h, subjected nary occlusion. to an enhanced chemiluminescence detection kit (Amer-HUCBC Treatment of Infarcted Hearts sham) for 60 s, and exposed on radiographic film (Amersham) for 90 s. The blots on the radiographic film
The myocardial infarctions following coronary artery ligation occupied 2.5 ± 0.5 out of 9 ventricular sections were then scanned and the protein densities determined with image analysis software (ImagePro). The results for and there were no significant differences in infarction sizes between rats randomized to HUCBC treatment or each cytokine were then normalized to positive controls present on each membrane. Mean ± SEM values were saline treatment. Injection of 10 6 HUCBC into infarcted rat myocardium within 2 h after acute coronary occlu-then determined for each cytokine/chemokine at 2, 6, 12, and 24 h after coronary occlusion. sion resulted in an infarction size at 1 month of 6.4 ± 0.01% of the left ventricular muscle area (n = 10) in Statistical Analyses comparison with infarction sizes of 24.5 ± 0.02% of the left ventricular area (p < 0.0001) in saline-treated in-All results are expressed as the mean ± SEM. The farcted rat hearts ( Fig. 5 ). HUCBC were also injected difference between the controls and treated groups was into infarcted rat hearts at 24 h after acute coronary octested by Dunnett's test. When multiple comparisons clusion. Injection of 10 6 HUCBC into infarcted rat myoamong groups were performed, analyses of variance cardium at 24 h after acute coronary occlusion resulted were performed and then the Bonferroni modification of in an infarction size in HUCBC-treated rats at 1 month the t-test was used for planned comparisons and Scheffe's of 8.4 ± 0.02% of the total left ventricular area, which procedure was used for post hoc comparisons. A value was significantly less than the infarcted hearts treated of p < 0.05 was considered significant. only with saline within 2 h and at 24 h (Fig. 5 ). There was no myocardial histological evidence of rejection as RESULTS evidenced by lack of focal or diffuse inflammatory cell Cell Migration infiltrates when the hearts were examined at 1 month in the rats that received the HUCBC. Representative myo-During the period in the Boyden chamber, 27,114 ± 4968 DAPI-labeled HUCBC migrated to normal myo-cardial slices stained with tetrazolium from HUCBCtreated infarcted hearts and saline-treated infarcted cardium. The migration of HUCBC to infarcted myocardium taken at 1-96 h after coronary occlusion fluctuated hearts are shown in Figure 6 . As shown in Figure 6A , in the representative 2-h saline-treated heart the infarct and reached maximum numbers at 2 h and at 24 h ( Fig.  3) . A total of 76,331 ± 3384 HUCBC migrated to in-area occupied 32% of the total left ventricular area. In the 2-h HUCBC-treated heart infarction the infarct area farcted myocardium taken from rat hearts 2 h after coronary occlusion and 69,911 ± 2732 HUCBC migrated to occupied 1.8% of the total left ventricular area. As shown in Figure 6B , the infarction in the 24-h saline-infarcted myocardium taken from rat hearts at 24 h after LAD occlusion (both p < 0.001 in comparison with nor-treated heart occupied 25% of the total left ventricular area while the infarction in the 24-h HUCBC-treated mal hearts). HUCBC also migrated to infarcted myocardium at the other times but the cell number did not heart occupied 9% of the total left ventricular area. achieve statistically significant differences from the nor-Cytokine Release mal control myocardium at the other times (p ≥ 0.05).
Because HUCBC migration to infarcted tissue may Acute myocardial infarction in rat hearts treated with only saline produced two-to sevenfold increases in the increase with escalating sizes of myocardial infarction and increasing amounts of inflammation, the left ventri-ventricular myocardial tissue concentrations of TNF-α, MCP-1, MIP, and INF-γ between 2 and 12 h after acute cle of each heart was divided into nine equal sections at the time of coronary occlusion and the number of sec-coronary occlusion (Fig. 7) . The increases in TNF-α, MCP-1, MIP, and INF-γ in these rat hearts were most tions occupied by each myocardial infarction were counted. We then divided the cell migration number by the pronounced at 12 h after acute coronary occlusion. TNFα increased from 6.9 ± 0.8% to 51.3 ± 4.6%, MCP-1 in-number of ventricular sections occupied by each infarction. When the HUCBC migration number to each heart creased from 10.5 ± 1.1% to 39.2 ± 2.0%, MIP increased from 10.6 ± 1.6% to 23.1.0 ± 1.5%, and INF-γ was corrected for the size of each myocardial infarction, the fluctuation of HUCBC migration to infarcted myo-increased from 8.9 ± 0.3% to 25.0 ± 1.7% (ANOVA, all p < 0.001). In contrast, the myocardial tissue concentra-cardium at each time was again evident. Significantly, tions of TNF-α, MCP-1, MIP, and INF-γ in rat hearts at 24 h after acute LAD occlusion resulted in myocardial infarction sizes in these rats at 1 month that were more treated with HUCBC did not significantly change at 2, 6, 12, or 24 h after coronary occlusion (Fig. 7) . than 50% smaller than the infarction sizes in rats treated only with saline. Moreover, the myocardial concentra-DISCUSSION tions of TNF-α, MCP-1, MIP, and INF-γ in the HUCBC-treated rat hearts did not significantly change In the present investigation, infarcted myocardium attracted the largest number of HUCBC at 2 h and at 24 from controls within the first 24 h after acute coronary occlusion, in contrast to two-to sevenfold increases in h after coronary artery occlusion. Injection of 1 million HUCBC in saline into infarcted rat hearts within 2 h or these cytokines/chemokines in infarcted rat hearts treated with only saline. The present investigations suggest that cent assay is not affected by filter pore size, cell density, filter composition, or filter thickness (14). With this infarcted myocardium significantly attracts HUCBC, that HUCBC can substantially reduce myocardial infarct technique, we were able to significantly limit variability in cell counts but detect substantial HUCBC migration size, and that HUCBC can limit inflammatory cytokine and chemokine expression in acutely infarcted myocar-to infarcted myocardium. Using similar techniques, HUCBC also have been demonstrated to significantly dium.
migrate to ischemic and infarcted cerebral tissue extracts Cell Migration Measurements taken at 24 h after carotid occlusion and bone marrow stem cells have been demonstrated to migrate to ische-Chemotaxis, or cell locomotion directed towards an attractant, occurs during many biological processes in-mic cerebral extracts at 6, 24, and 48 h after carotid occlusion (9,10,28). In the present experiments we ob-cluding fertilization, embryonic development, hematopoiesis, tissue inflammation, and wound healing. A vari-served that the attraction of acutely ischemic/infarcted myocardium for HUCBC fluctuates over time. This fluc-ety of methods have been devised to assay chemotaxis, including migration of cells under an agarose layer, pha-tuation in myocardial attraction for progenitor cells is most likely due to variations in the number or type of gokinetic tract assays, cell orientation assays, time-lapse cinematography, and Boyden apparatus assays (14). The inflammatory cells and/or the concentrations of chemoattractants within the ischemic and infarcted myocar-Boyden apparatus assay is a widely used method to measure chemotaxis (14). The chemotactic response with dium. this assay can be analyzed by either manually measuring Limitation of Myocardial Infarct Size the distance traveled by cells or by visually quantifying the number of cells in the wells of the lower chamber To date embryonic, skeletal muscle, and bone marrow stem cells have been transplanted into damaged of the Boyden apparatus. However, these methods are laborious and prone to subjective bias. Consequently, hearts to improve heart function (26) . The largest experience to date has been with the use of myoblasts isolated spectrophotometric, fluorescent or radiolabel techniques have been developed that provide precise quantification from skeletal muscle for heart repair. Injection of skeletal myoblasts directly into infarcted hearts or into the of cell migration in the Boyden apparatus. We therefore used a DAPI fluorescent label for HUCBC and mea-coronary arteries of infarcted hearts can limit left ventricular remodeling after myocardial infarction (15). sured the fluorescence of the migrated cells. The fluores- However, these cells mature into well-differentiated Human umbilical cord blood is an extremely rich source of hematopoietic and mesenchymal progenitor skeletal muscle cells, not cardiac muscle cells, and communication with host cardiomyocytes in the heart via cells (4, 5) . The total content of hematopoietic progenitor cells in umbilical cord blood equals or exceeds that in gap junction proteins is poor or nonexistent (26) . Consequently, cardiac arrhythmias can occur because of elec-bone marrow, and the highly proliferative hematopoietic progenitor cells are eightfold higher in HUCBC than in trical reentry in islands of skeletal muscle in the myocardium (25) .
bone marrow (4,5,7). The immunotype and functional properties displayed by human cord blood mesenchymal Recently investigators have discovered that bone marrow hematopoietic and mesenchymal stem cells have the cells closely resembles the characteristics of bone marrow-derived mesenchymal progenitor cells, and mesen-capacity to limit myocardial infarction size and augment ventricular systolic wall thickening (26, 30) . However, chymal and hematopoietic progenitor cells in umbilical cord blood can be expanded in tissue culture by as much the isolation, expansion, and preparation of bone marrow stem cells for therapeutic uses can require several as 77-95% (5, 6, 12) . The percentage of primitive CD34 cells in umbilical cord blood decreases from 6% to 3% days (36) . In addition, the transplantation of allogeneic bone marrow stem cells usually requires the use of im-from gestations of 17-32 weeks and is approximately 1% for gestations of 37-41 weeks (34) . HUCBC can be munosuppressant drugs in the recipient, which may contribute to an immature transplant stem cell phenotype cryopreserved for as long as 15 years with recovery of 60-100% viable progenitor cells (5, 7) . and subject the host to possible complications of infection or malignancy.
Cord blood mononuclear cells have longer telomeres than adult bone marrow cells, which indicates that late after acute coronary occlusion and myocardial infarction, in contrast to primary thrombolytic therapy or HUCBC have undergone less cell division and are more immature than adult bone marrow stem cells (37) . A primary angioplasty, and still produce substantial therapeutic effects. distinct advantage of HUCBC over bone marrow stem cells is the immature immunogenicity of these cells, Human umbilical cord blood cells have also been administered for the treatment of acute stroke and trau-which is very similar to fetal stem cells and which significantly reduces the risks of rejection by the transplant matic brain injury in rats (9,24,38). In rats with stroke due to middle cerebral artery occlusion, HUCBC treat-recipient or graft versus host disease in patients who are immunocompromised (4, 5) . In this regard, HUCBC T-ment at 24 h after acute stroke decreased brain infarct volume by 65% in comparison with untreated rats (38). lymphocytes are phenotypically and functionally naive and generally have experienced little or no antigen expo-Moreover, the decrease in brain infarct volume was associated with a 25% increase in the rotarod test of physi-sure. HUCBC T-lymphocytes express predominantly a naive form of CD45RA in contrast to human adult cal agility and a 44% decrease in the Modified Neurological Severity Score (9,38). Similarly, in rats with blood T cells that express a mature, memory isoform of CD45RO that is important in antibody production and traumatic brain injury, HUCBC treatment produced a 20% improvement in the rotarod test and a 55% de-cell proliferation (17, 18, 32) . The majority of the CD45RA T cells that are expressed in cord blood do not produce crease in the neurological severity scores (24) . Taken together, these studies suggest that HUCBC can signifi-CD40 ligand, which is important in the B cell maturation (17,32). Consequently, umbilical cord blood B cells cantly limit the size of major organ infarctions. have intrinsic inabilities to produce immunoglobulins Myocardial Infarction Chemoattractants (18) . The presence of the naive from of CD45RA and the lack of CD40 ligand production contribute to the Cytokine and chemokine expression play an important role in inflammatory cell recruitment and are a immature immunogenicity of HUCBC (17, 32) . In addition, HUCBC produce less cytokine IL-2, IL-3, INF-γ, prominent feature of the inflammatory response with myocardial infarction. In the present experiments, TNF-and TNF-α than adult blood (13). For all these reasons human umbilical cord blood has been used as a source α, MCP-1, MIP, and INF-γ were increased two-to sevenfold in infarcted rat hearts treated with saline. The of marrow repopulating stem cells in patients treated for leukemia, myelodysplastic syndromes, neuroblastoma, triggers of cytokine release in myocardial infarction include myocardial ischemia, reactive oxygen species, and Fanconi's anemia, and aplastic anemia, and more than 3000 human cord blood transplants have been performed mechanical deformation of the ventricular wall (29) . The proinflammatory cytokine TNF-α activates cytotoxic T in patients with these disorders (4, 5) .
We have recently begun to investigate the use of cells and matrix metalloproteinases, induces apoptosis, depresses LV function, and ultimately causes ventricular HUCBC as a source of stem cells for the treatment of acute myocardial infarction (20, 21) . In our initial study, remodeling (19, 29) . Serum concentrations of TNF-α after acute myocardial infarction correlate with collagen we injected 1 million HUCBC directly into infarcted myocardium of rats after permanent coronary occlusion deposition in the heart and with increased LV end-diastolic diameter (35) . Moreover, TNF-α in combination with and observed after 1 to 3-4 months the presence of HUCBC and infarction sizes in the HUCBC-treated rats IFN-γ promotes induction of intercellular adhesion molecule-1 (ICAM-1), neutrophil adhesion to myocytes and that were significantly smaller than untreated infarcted rat hearts (20) . The reduction in infarction sizes in the endothelial cells, and cell dysfunction (22) . Conversely, in animal models of myocardial infarction in which the HUCBC-treated rats in our initial study was associated with LV ejection fractions and wall thickening, deter-TNF-α gene is ablated or TNF-α is inhibited with antibodies, there is a significant reduction in infarction size mined by echocardiography, that were 35% and 112% greater, respectively, than the untreated, infarcted rats and an increase in left ventricular ejection fraction (22, 23) . MCP-1 and MIP play major roles in the chemoattrac-when measured at 4-5 months after the coronary occlusions and were similar to normal, unoperated control rats tion of monocytes to an inflammatory focus. MCP-1 is a potent chemoattractant for macrophages, T cells and of the same age (20) . Moreover, neither the HUCBCtreated rats in our initial study nor the rats in the present natural killer cells, cytokine synthesis, reperfusion injury, and formation of granulation tissue in the healing study received any immunosuppressive therapy. In the present experiments the infarction sizes in rat hearts myocardial infarct (23) . MCP-1 can also stimulate the expression of ICAM-1 and thereby cause the adhesion treated within 2 h and also at 24 h after coronary occlusion were more than 50-60% smaller than the infarction of neutrophils to cardiac myocytes (3) . In contrast, the inhibition or ablation of MCP-1 results in the attenuation sizes in untreated rats. The results in the rats treated at 24 h suggest that HUCBC can be administered relatively of postinfarction LV remodeling (11). MCP-1 also plays
